236 related articles for article (PubMed ID: 14603436)
21. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
Zhao H; Kim Y; Wang P; Lapointe J; Tibshirani R; Pollack JR; Brooks JD
Prostate; 2005 May; 63(2):187-97. PubMed ID: 15486987
[TBL] [Abstract][Full Text] [Related]
23. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
24. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
25. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
Sugimoto T; Arai M; Shimada H; Hata A; Seki N
Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
[TBL] [Abstract][Full Text] [Related]
26. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
[TBL] [Abstract][Full Text] [Related]
27. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
28. Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
Ruiz C; Holz DR; Oeggerli M; Schneider S; Gonzales IM; Kiefer JM; Zellweger T; Bachmann A; Koivisto PA; Helin HJ; Mousses S; Barrett MT; Azorsa DO; Bubendorf L
J Pathol; 2011 Mar; 223(4):543-52. PubMed ID: 21294127
[TBL] [Abstract][Full Text] [Related]
29. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
Vijayakumar S; Hall DC; Reveles XT; Troyer DA; Thompson IM; Garcia D; Xiang R; Leach RJ; Johnson-Pais TL; Naylor SL
Cancer Res; 2006 Apr; 66(8):4055-64. PubMed ID: 16618725
[TBL] [Abstract][Full Text] [Related]
30. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
[TBL] [Abstract][Full Text] [Related]
31. Amplification of urokinase gene in prostate cancer.
Helenius MA; Saramäki OR; Linja MJ; Tammela TL; Visakorpi T
Cancer Res; 2001 Jul; 61(14):5340-4. PubMed ID: 11454671
[TBL] [Abstract][Full Text] [Related]
32. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
[TBL] [Abstract][Full Text] [Related]
33. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
34. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
36. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer expression profiling by cDNA sequencing analysis.
Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L
Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429
[TBL] [Abstract][Full Text] [Related]
38. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
[TBL] [Abstract][Full Text] [Related]
39. Expression of ezrin in prostatic intraepithelial neoplasia.
Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
[TBL] [Abstract][Full Text] [Related]
40. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
Thelen P; Burfeind P; Grzmil M; Voigt S; Ringert RH; Hemmerlein B
Int J Oncol; 2004 May; 24(5):1085-92. PubMed ID: 15067329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]